cardiovascular disease cardiac patients
Conditions
Interventions
The intervention group will receive standard CR along with the RESST
intervention, consisting of 5-6 on-site group sessions integrating principles
from Acceptance and Commitment Therapy and Cognitiv
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1) Participating in cardiac rehabilitation 2) age above 18 years, 3) proficient in the Dutch language, 4) experiencing sleep and/or stress problems as indicated by a high score on the Pittsburgh Sleep Quality Index (PSQI score >5) or Perceived Stress Scale-10 (PSS-10 score >13)
Exclusion criteria
Exclusion criteria: 1) severe psychiatric, cognitive or physical comorbidity that would impede cardiac rehabilitation participation. 2) active treatment for sleep disorders, stress, or other forms of (behavioural) therapy at the start of the study or expected to start within the first 6 months of the study, that could interfere with the RESST intervention. Note: Participants with previously diagnosed sleep disorders are eligible if they still experience sleep or stress problems, unless they fall under the above criteria. Participants who received a prior treatment that is still ongoing but has resulted in a stable sleep and stress condition in the 3 months before the cardiovascular event (e.g., Continuous Positive Airway Pressure (CPAP)) are eligible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes of the study include both objective and subjective measures of sleep, as well as perceived stress. These outcomes will be assessed before and after the intervention, as well as at a 6-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes encompass quality of life, chronic stress biomarkers, cardiometabolic risk factors, physical fitness, lifestyle components and psychosocial wellbeing. These outcomes will be assessed before and after the intervention, as well as at a 6-month follow-up. | — |
Countries
Netherlands
Contacts
Public ContactN. Hoeve
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed